“Myxovirus Resistance, Osteopontin and Suppressor of Cytokine Signaling 3 Polymorphisms Predict Hepatitis C Virus Therapy Response in an Admixed Patient Population: Comparison With IL28B”. 2013. Clinics 68 (10): 1325-32. https://doi.org/10.1590/clin.v68i10.77009.